Musculoskeletal Drugs Approved by the FDA (2007)

Musculoskeletal

Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
    
Reclast (zoledronic acid); For the treatment of postmenopausal osteoporosis; Novartis; Approved August 2007
    
Reclast (zoledronic acid); For the treatment of Paget's disease; Novartis Pharms; Approved April 2007
    
Somatuline Depot (lanreotide acetate); For the treatment of acromegaly; Beaufour Ipsen; Approved August 2007